Fennec Pharmaceuticals Inc.

Healthcare

NASDAQ:FENC · NASDAQ Capital Market

Market Cap $258.94M Beta 1.08 P/E (TTM) -36.3

$9.06 -1.34%

-$0.12 today

52W Low $5.65High $10.45

Vol 0.37M · Avg 0.26M

EPS (TTM) -$0.24Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+12.27%

Period High

$9.98

Period Low

$5.77

Latest

$9.06

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Prelude Therapeutics Incorporated

NASDAQ:PRLD

$327.34M

Enanta Pharmaceuticals, Inc.

NASDAQ:ENTA

$291.48M

Nautilus Biotechnology, Inc.

NASDAQ:NAUT

$280.98M

Cartesian Therapeutics, Inc.

NASDAQ:RNAC

$277.66M

Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

$234.31M

Eupraxia Pharmaceuticals Inc.

NASDAQ:EPRX

$214.39M

Avalo Therapeutics, Inc.

NASDAQ:AVTX

$170.65M

Caribou Biosciences, Inc.

NASDAQ:CRBU

$158.17M

Black Diamond Therapeutics, Inc.

NASDAQ:BDTX

$93.69M

Aardvark Therapeutics, Inc. Common Stock

NASDAQ:AARD

$85.95M

What is the latest FENC filing?

The latest filing shown is S-8 dated Jun 11, 2026.

How many recent filings does FENC have?

Intrinsic Alpha currently shows 20 recent filings for FENC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.